INIS
patients
100%
cancer
100%
blood
100%
pancreas
100%
thrombin
100%
adenocarcinomas
66%
control
33%
blood cells
33%
plasma
33%
comparative evaluations
25%
risks
16%
thrombosis
16%
diseases
8%
sex
8%
peaks
8%
capacity
8%
coagulants
8%
Keyphrases
Pancreatic Cancer
100%
Whole Blood
100%
Platelets
100%
Thrombin Generation
100%
Pancreatic Ductal Adenocarcinoma
88%
Lag Time
33%
Blood Cells
33%
Venous Thromboembolism
22%
Healthy Controls
11%
6-month Follow-up
11%
Major Complications
11%
Time to Peak
11%
Thrombosis
11%
Hemostasis
11%
Coagulation
11%
Endogenous Thrombin Potential
11%
Granules
11%
Coagulant
11%
Complete Blood Count
11%
Risk Estimation
11%
Procoagulant Effect
11%
Granule Release
11%
Coagulation Profile
11%
High Thrombotic Risk
11%
Thrombosis Risk
11%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombin
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
100%
Thromboembolism
50%
Venous Thromboembolism
25%
Procoagulant
25%
Thrombosis
25%
Risk Evaluation
12%
Blood Stasis
12%
Nursing and Health Professions
Thrombin
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
100%
Thromboembolism
50%
Venous Thromboembolism
25%
Thrombosis
25%
Procoagulant
25%
Blood Cell Count
12%
Biochemistry, Genetics and Molecular Biology
Platelet
100%
Thrombin
100%
Blood Plasma
80%
Hemocyte
20%
Hemostasis
20%
Blood Cell Count
20%
Immunology and Microbiology
Platelet
100%
Thrombin
100%
Blood Plasma
80%
Hemocyte
20%
Hemostasis
20%
Blood Cell Count
20%
Neuroscience
Thrombin
100%
Platelet
100%
Blood Plasma
80%
Hemocyte
40%
Hemostasis
20%